High margin Medacta leads the way in pre-Easter IPO reopening

Swiss-Exchange_Zurich_230x150
By Sam Kerr
11 Mar 2019

Medacta, the Swiss maker of artificial human joints, has begun a process to list on the SIX Swiss Exchange before Easter. If it succeeds, it would be the first major company to complete an IPO in Europe this year.

Credit Suisse and Morgan Stanley are global coordinators, JP Morgan and UBS bookrunners.

The IPO consists of an all-secondary share sale by the family of Alberto Siccardi, who founded the company in 1999 and remains its chairman. Francesco Siccardi is the CEO.

Medacta’s main offerings are ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.